Oftentimes medical practice recommendations are undergirded by expert opinion rather than by multiple randomized control trials and can't quite answer the questions patients and their families have about what treatment is best for them, write Francis Collins, the director of the US National Institutes of Health, Kathy Hudson, the deputy director for science, outreach, and policy at NIH, and their colleagues in a commentary appearing in the Journal of the American Medical Informatics Asso

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.